FGF7 and multiple sclerosis: While animal studies consistently reported thymic recovery and enhanced T cell output following KGF administration (25, 29, 59, 60), recent clinical trials have failed to demonstrate improved thymopoiesis in patients with multiple sclerosis (26) and HIV (27).